Insiders Moderna, Inc.

Equities

MRNA

US60770K1079

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-22 pm EST			Pre-market 09:22:00 am
38.50 ^USD	+7.27%		38.96	+1.21%

Jan. 21	Sector Update: Health Care Stocks Higher Late Afternoon	MT
Jan. 21	Top Midday Gainers	MT

Insiders

Top Midday Stories: Vaccine Stocks Fall on RFK Jr. HHS Nomination; GM Plans to Cut 1,000 Salaried Workers	Nov. 15	MT
Moderna, Novavax, Pfizer Shares Fall on Nomination of Anti-Vaxxer as US Health Secretary	Nov. 15	MT
Bancel Steps Down as Moderna Sales Chief, Keeps CEO Post	Nov. 05	MT
Moderna's Bancel Steps Down as Sales Chief, Keeps CEO Post, Bloomberg Reports	Nov. 05	MT
Moderna CEO Bancel steps down as sales chief, Bloomberg News reports	Nov. 05	RE
NovoCure Limited Appoints Christoph Brackmann as Senior Financial Advisor	24-10-30	CI
NovoCure Limited Announces CFO Appointment	24-10-30	CI
Certara, Inc. Appoints John Reynders as Independent Board Member	24-10-16	CI
Cosmo Pharmaceuticals CFO to Shift to New Role; Successor Named	24-10-11	MT
Moderna: Abbas Hussain joins the Board of Directors	24-10-02	CF
Moderna, Inc. Appoints Abbas Hussain to Board of Directors	24-10-02	CI
Klotho Neurosciences, Inc. Appoints Robert Langer to Its Scientific Advisory Board	24-09-29	CI
Moderna Insider Sold Shares Worth $1,766,972, According to a Recent SEC Filing	24-07-29	MT
Moderna: David Rubenstein joins the Board of Directors	24-07-23	CF
Moderna, Inc. Announces Board Changes	24-07-23	CI
Moderna Insider Sold Shares Worth $1,842,651, According to a Recent SEC Filing	24-07-22	MT
Moderna Insider Sold Shares Worth $1,756,177, According to a Recent SEC Filing	24-07-15	MT
Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with Moderna	24-06-27	CI
Moderna Insider Sold Shares Worth $30,087,339, According to a Recent SEC Filing	24-06-12	MT
Moderna Insider Sold Shares Worth $2,901,585, According to a Recent SEC Filing	24-06-03	MT
Moderna Insider Sold Shares Worth $1,909,863, According to a Recent SEC Filing	24-05-20	MT
Moderna Insider Sold Shares Worth $1,912,350, According to a Recent SEC Filing	24-05-17	MT
Moderna Insider Sold Shares Worth $1,825,220, According to a Recent SEC Filing	24-05-13	MT
Novavax Surges on $1.2 Billion Sanofi Vaccine Deal	24-05-10	MT

Become a member to access more news.

100% Free Registration

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Moderna, Inc. prepares for the post-Covid era

March 25, 2024 at 10:24 am EDT

Stéphane Bancel, CEO of Moderna: Restoring confidence in the vaccines sector

January 16, 2024 at 03:31 pm EST